Nuvasive Inc (NUVA) 66.77 $NUVA Varian Medical
Post# of 273254
Posted On: 09/25/2016 5:08:52 PM
Nuvasive Inc (NUVA) 66.77 $NUVA
Varian Medical Hits 52-Week High; Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 10:29AM CDT
Share price of Varian Medical Systems Inc. (VAR) rallied to a new 52-week high of $98.73 on Sep 22.
VAR: 98.17 (-0.33), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 10:26AM CDT
Becton, Dickinson and Company (BDX) announced that it is expanding capacity at its Holdrege, NE facility.
BDX: 179.50 (-2.05), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Hill-Rom Holdings Hits a 52-Week High on Solid Prospects
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 8:47AM CDT
Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) reached a new 52-week high of $60.92 on Sep 22, eventually closing a tad lower at $60.84.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29), HRC: 60.78 (-0.06)
Becton, Dickinson (BDX) Launch Wireless Diagnostic Device
Zacks Equity Research - Zacks Investment Research - Thu Sep 22, 7:28AM CDT
Becton, Dickinson and Company (BDX) announced the launch of BD Veritor Plus System.
BDX: 179.50 (-2.05), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Zimmer Biomet Introduces Vanguard Individualized Design
Zacks Equity Research - Zacks Investment Research - Wed Sep 21, 8:17AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) recently announced the launch of Vanguard Individualized Design (ID), an advanced total knee arthroplasty (TKA) system.
ZBH: 128.33 (-0.54), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Acadia Healthcare to Serve FBINAA as Treatment Provider
Zacks Equity Research - Zacks Investment Research - Wed Sep 21, 7:30AM CDT
Acadia Healthcare Company Inc. (ACHC) recently announced that it has become the select provider of behavioral health and addiction treatment services to the FBI National Academy Associates.
ACHC: 49.54 (-0.78), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
NuVasive Shares Up 53.8% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Wed Sep 21, 12:23AM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 7 months, NuVasive has returned 53.84% as of today's recent price of $66.89.
NUVA: 66.77 (-1.29)
The Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory to Join S&P SmallCap 600
PR Newswire - Tue Sep 20, 5:15PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices effective after the close of trading on Thursday, September 22:
SPGI: 124.98 (-1.85), TMO: 157.66 (unch), SPSC: 72.71 (-0.71), NWE: 59.91 (-0.19), MAR: 68.44 (-1.31), FOXF: 22.42 (+0.30), NUVA: 66.77 (-1.29), COO: 180.97 (-3.53), FEIC: 106.89 (+0.09), HOT: 77.05 (-0.20)
Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 9:53AM CDT
Boston Scientific Corporation (BSX) recently announced the receipt of the European CE mark for its LOTUS Edge Valve System.
BSX: 23.71 (-0.02), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
NuVasive Grows in Pediatric Spine with FDA 510(k) for MAGEC
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 7:09AM CDT
NuVasive, Inc. (NUVA) got the U.S. FDA 510(k) nod for its MAGEC system to be implanted using its Reline posterior fixation system for the treatment of severe spinal deformities.
GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Healthways Announces Reorganization, Management Changes
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 5:24AM CDT
Healthways Inc. (HWAY) announced structural reorganization that will allow it to focus more effectively on growth and improvement of financial performance.
GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), HWAY: 25.80 (-0.62), NUVA: 66.77 (-1.29)
Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 4:42AM CDT
Shares of Masimo Corp. (MASI) scaled a new 52-week high of $60.05 on Sep 19.
MASI: 59.77 (-0.55), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
NuVasive Receives FDA 510(k) Clearance Reinforcing Comprehensive Portfolio Supporting Pediatric, Adolescent and Adult Spinal Deformity Patients
Marketwired - Mon Sep 19, 10:16AM CDT
Innovative NuVasive Spinal Deformity Technology Helps Leading Shriners Hospitals for Children -- Los Angeles Surgeon in Treating Six-Year-Old With Early Onset Scoliosis and Severe Kyphosis
NUVA: 66.77 (-1.29)
Walgreens Partners EnvisionRx on 90-day Health Program
Zacks Equity Research - Zacks Investment Research - Mon Sep 19, 9:35AM CDT
Walgreens announced a 90-day pharmacy program in collaboration with EnvisionRx, the pharmacy benefit management (PBM) division of EnvisionRxOptions.
WBA: 82.05 (-0.33), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Varian Medical (VAR) Receives FDA Clearance for Nexus DR
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 10:06AM CDT
Varian Medical Systems (VAR) recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market Nexus DR.
VAR: 98.17 (-0.33), GWPH: 107.56 (-2.20), LNTH: 8.49 (-0.58), NUVA: 66.77 (-1.29)
Glaukos Hits a 52-Week High on Positive Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:26AM CDT
Share price of Laguna Hills, CA-based Glaukos Corporation (GKOS) reached a new 52-week high of $35.75 on Sep 15, finally closing lower at $37.42 yesterday.
GWPH: 107.56 (-2.20), GKOS: 39.15 (+0.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Cepheid Announces Expansion of Molecular C. Difficile Product
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:21AM CDT
Cepheid (CPHD) recently announced expansion of its Molecular C. Difficile Xpert assay to simplify the detection of C. difficile strains.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), CPHD: 52.50 (unch), NUVA: 66.77 (-1.29)
Zimmer Biomet Buys Clinical Graphics, Boosts Hip Business
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:12AM CDT
Zimmer Biomet (ZBH) major has now announced the buyout of Clinical Graphics, B.V., an imaging company that works on 3D range-of-motion simulation technology.
ZBH: 128.33 (-0.54), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Medidata Solutions & University of Carolina Wilmington Tie Up
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:06AM CDT
Medidata Solutions Inc. (MDSO), a NY-based global provider of clinical and cloud-based solutions for life sciences companies, announced a strategic partnership with University of North Carolina Wilmington.
MDSO: 56.51 (-0.08), INCR: 44.94 (+0.54), LNTH: 8.49 (-0.58), NUVA: 66.77 (-1.29)
Varian Medical Hits 52-Week High; Oncology Prospects Bright
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 10:29AM CDT
Share price of Varian Medical Systems Inc. (VAR) rallied to a new 52-week high of $98.73 on Sep 22.
VAR: 98.17 (-0.33), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 10:26AM CDT
Becton, Dickinson and Company (BDX) announced that it is expanding capacity at its Holdrege, NE facility.
BDX: 179.50 (-2.05), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Hill-Rom Holdings Hits a 52-Week High on Solid Prospects
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 8:47AM CDT
Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) reached a new 52-week high of $60.92 on Sep 22, eventually closing a tad lower at $60.84.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29), HRC: 60.78 (-0.06)
Becton, Dickinson (BDX) Launch Wireless Diagnostic Device
Zacks Equity Research - Zacks Investment Research - Thu Sep 22, 7:28AM CDT
Becton, Dickinson and Company (BDX) announced the launch of BD Veritor Plus System.
BDX: 179.50 (-2.05), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
Zimmer Biomet Introduces Vanguard Individualized Design
Zacks Equity Research - Zacks Investment Research - Wed Sep 21, 8:17AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) recently announced the launch of Vanguard Individualized Design (ID), an advanced total knee arthroplasty (TKA) system.
ZBH: 128.33 (-0.54), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Acadia Healthcare to Serve FBINAA as Treatment Provider
Zacks Equity Research - Zacks Investment Research - Wed Sep 21, 7:30AM CDT
Acadia Healthcare Company Inc. (ACHC) recently announced that it has become the select provider of behavioral health and addiction treatment services to the FBI National Academy Associates.
ACHC: 49.54 (-0.78), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
NuVasive Shares Up 53.8% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Wed Sep 21, 12:23AM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 7 months, NuVasive has returned 53.84% as of today's recent price of $66.89.
NUVA: 66.77 (-1.29)
The Cooper Companies Set to Join the S&P 500; Northwestern and NuVasive to Join S&P MidCap 400; SPS Commerce and Fox Factory to Join S&P SmallCap 600
PR Newswire - Tue Sep 20, 5:15PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices effective after the close of trading on Thursday, September 22:
SPGI: 124.98 (-1.85), TMO: 157.66 (unch), SPSC: 72.71 (-0.71), NWE: 59.91 (-0.19), MAR: 68.44 (-1.31), FOXF: 22.42 (+0.30), NUVA: 66.77 (-1.29), COO: 180.97 (-3.53), FEIC: 106.89 (+0.09), HOT: 77.05 (-0.20)
Boston Scientific's LOTUS Edge Valve System Gets CE Mark
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 9:53AM CDT
Boston Scientific Corporation (BSX) recently announced the receipt of the European CE mark for its LOTUS Edge Valve System.
BSX: 23.71 (-0.02), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
NuVasive Grows in Pediatric Spine with FDA 510(k) for MAGEC
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 7:09AM CDT
NuVasive, Inc. (NUVA) got the U.S. FDA 510(k) nod for its MAGEC system to be implanted using its Reline posterior fixation system for the treatment of severe spinal deformities.
GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Healthways Announces Reorganization, Management Changes
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 5:24AM CDT
Healthways Inc. (HWAY) announced structural reorganization that will allow it to focus more effectively on growth and improvement of financial performance.
GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), HWAY: 25.80 (-0.62), NUVA: 66.77 (-1.29)
Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 4:42AM CDT
Shares of Masimo Corp. (MASI) scaled a new 52-week high of $60.05 on Sep 19.
MASI: 59.77 (-0.55), GWPH: 107.56 (-2.20), BAX: 47.49 (-0.71), NUVA: 66.77 (-1.29)
NuVasive Receives FDA 510(k) Clearance Reinforcing Comprehensive Portfolio Supporting Pediatric, Adolescent and Adult Spinal Deformity Patients
Marketwired - Mon Sep 19, 10:16AM CDT
Innovative NuVasive Spinal Deformity Technology Helps Leading Shriners Hospitals for Children -- Los Angeles Surgeon in Treating Six-Year-Old With Early Onset Scoliosis and Severe Kyphosis
NUVA: 66.77 (-1.29)
Walgreens Partners EnvisionRx on 90-day Health Program
Zacks Equity Research - Zacks Investment Research - Mon Sep 19, 9:35AM CDT
Walgreens announced a 90-day pharmacy program in collaboration with EnvisionRx, the pharmacy benefit management (PBM) division of EnvisionRxOptions.
WBA: 82.05 (-0.33), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Varian Medical (VAR) Receives FDA Clearance for Nexus DR
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 10:06AM CDT
Varian Medical Systems (VAR) recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market Nexus DR.
VAR: 98.17 (-0.33), GWPH: 107.56 (-2.20), LNTH: 8.49 (-0.58), NUVA: 66.77 (-1.29)
Glaukos Hits a 52-Week High on Positive Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:26AM CDT
Share price of Laguna Hills, CA-based Glaukos Corporation (GKOS) reached a new 52-week high of $35.75 on Sep 15, finally closing lower at $37.42 yesterday.
GWPH: 107.56 (-2.20), GKOS: 39.15 (+0.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Cepheid Announces Expansion of Molecular C. Difficile Product
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:21AM CDT
Cepheid (CPHD) recently announced expansion of its Molecular C. Difficile Xpert assay to simplify the detection of C. difficile strains.
GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), CPHD: 52.50 (unch), NUVA: 66.77 (-1.29)
Zimmer Biomet Buys Clinical Graphics, Boosts Hip Business
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:12AM CDT
Zimmer Biomet (ZBH) major has now announced the buyout of Clinical Graphics, B.V., an imaging company that works on 3D range-of-motion simulation technology.
ZBH: 128.33 (-0.54), GWPH: 107.56 (-2.20), QDEL: 22.71 (-0.08), NUVA: 66.77 (-1.29)
Medidata Solutions & University of Carolina Wilmington Tie Up
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:06AM CDT
Medidata Solutions Inc. (MDSO), a NY-based global provider of clinical and cloud-based solutions for life sciences companies, announced a strategic partnership with University of North Carolina Wilmington.
MDSO: 56.51 (-0.08), INCR: 44.94 (+0.54), LNTH: 8.49 (-0.58), NUVA: 66.77 (-1.29)
(0)
(0)Scroll down for more posts ▼